Tauriga Sciences Inc (TAUG)
0.00
USD |
OTCM |
Apr 22, 16:00
Tauriga Sciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2021 | -1.957 |
September 30, 2021 | -50.65 |
June 30, 2021 | 0.801 |
March 31, 2021 | 0.3971 |
December 31, 2020 | 0.7477 |
September 30, 2020 | 8.680 |
June 30, 2020 | -11.59 |
March 31, 2020 | -2.061 |
December 31, 2019 | -5.754 |
September 30, 2019 | 1.359 |
June 30, 2019 | 0.4533 |
March 31, 2019 | 0.4248 |
December 31, 2018 | 3.477 |
September 30, 2018 | 0.4154 |
June 30, 2018 | 0.4044 |
March 31, 2018 | 0.8568 |
December 31, 2017 | 0.565 |
September 30, 2017 | -0.2747 |
June 30, 2017 | -0.2673 |
March 31, 2017 | -0.2778 |
December 31, 2016 | -0.0829 |
September 30, 2016 | -0.0537 |
June 30, 2016 | -0.0646 |
March 31, 2016 | -0.119 |
December 31, 2015 | -0.1314 |
Date | Value |
---|---|
September 30, 2015 | -0.0834 |
June 30, 2015 | -0.124 |
March 31, 2015 | -0.0369 |
December 31, 2014 | 0.0649 |
September 30, 2014 | 0.073 |
June 30, 2014 | 0.0636 |
March 31, 2014 | -0.1661 |
December 31, 2013 | 2.352 |
September 30, 2013 | -0.841 |
June 30, 2013 | -0.5572 |
March 31, 2013 | -0.3366 |
December 31, 2012 | -0.2572 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | -2.566 |
December 31, 2011 | -0.3627 |
September 30, 2011 | -0.3622 |
June 30, 2011 | -0.5389 |
March 31, 2011 | -0.4579 |
December 31, 2010 | -0.4194 |
September 30, 2010 | -0.4938 |
June 30, 2010 | -0.454 |
March 31, 2010 | -0.5485 |
December 31, 2009 | -0.2091 |
September 30, 2009 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-50.65
Minimum
Sep 2021
8.680
Maximum
Sep 2020
-5.416
Average
0.3971
Median
Mar 2021
Debt to Equity Ratio Benchmarks
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.617M |
Total Liabilities (Quarterly) | 2.362M |
Shareholders Equity (Quarterly) | -0.7457M |